Regeneron (NASDAQ: REGN) reported Q4 EPS of $9.53, $1.10 better than the analyst estimate of $8.43. Revenue for the quarter came in at $2.42 billion versus the consensus estimate of $2.42 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.